Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10435355
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
granted -
US 10435399
HDAC6 inhibitory heterocyclic compound
granted -
US 10434075
FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer
granted -
US 10434096
Tyrosine kinase inhibitors
granted -
US 10428157
Dosing regimens for use with PCSK9 inhibitors
granted -
US 10428057
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
granted -
US 10426767
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10428028
HDAC inhibitors
granted -
US 10428050
Substituted reverse pyrimidine Bmi-1 inhibitors
granted -
US 10420813
Competitive inhibitors of invariant chain expression and/or ectopic clip binding
granted -
US 10421802
Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (MERS-CoV) and engineered bispecific fusions with inhibitory peptides
granted -
US 10421765
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
granted -
US 10420758
Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof
granted -
US 10414740
Glutaminase inhibitors and method of use
granted -
US 10416163
Method and treatment of recurring endometrial cancer with an inhibitor of USP14
granted -
US 10407445
Hepatitis C virus inhibitors
granted -
US 10407409
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
granted -
US 10406148
Methods of treatment using a JAK inhibitor compound
granted -
US 10400010
Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
granted -
US 10398706
Heteroaryldiazepine derivatives as RSV inhibitors
granted -
US 10392386
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10392391
Compounds useful as inhibitors of ATR kinase
granted -
US 10391175
BET bromodomain inhibitors and therapeutic methods using the same
granted -
US 10391095
DNA-PK inhibitors
granted